Format

Send to

Choose Destination
Clin Liver Dis. 2014 Feb;18(1):157-63. doi: 10.1016/j.cld.2013.09.006. Epub 2013 Oct 24.

The impact of obesity and metabolic syndrome on alcoholic liver disease.

Author information

1
Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic, A51, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

Abstract

Alcoholic liver disease (ALD) remains a major cause of chronic liver diseases and liver failure. Population-based prospective studies and patient cohort studies have demonstrated that obesity and the metabolic syndrome exacerbate progression of ALD and increase hepatocellular carcinoma (HCC) incidence and mortality. Emerging evidence also suggests a synergism between alcohol and obesity in mortality and HCC incidence. Recognition of these increased risks and detection of early-stage liver disease may offer the opportunity to address these modifiable risk factors and prevent disease progression in these patients.

KEYWORDS:

Alcoholic liver disease; Diabetes; Insulin resistance; Metabolic syndrome; Obesity

PMID:
24274871
PMCID:
PMC6130318
DOI:
10.1016/j.cld.2013.09.006
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center